By Balazs Koranyi FRANKFURT (Reuters) -European Central Bank policymakers backed further policy easing on Friday just a day after the bank’s fourth straight rate cut, despite fresh surveys pointing to continued inflation momentum. The ECB cut interest rates to 2.75% on Thursday and said that borrowing costs would remain on a downward path as the …
ECB policymakers hint at more rate cuts on inflation optimism Read More »
(Reuters) – German agricultural group BayWa has initiated restructuring proceedings at a court in Munich in an effort to circumvent a minority of creditors opposed to its plan, the company said on Friday. Shares in BayWa slumped by as much as a third following the announcement, and were seen down 3.47% at 1021 GMT. Shareholders …
Shares fall after Germany’s BayWa seeks to push through restructuring in court Read More »
(Reuters) – Global equity funds witnessed a surge in investments in the week through Jan. 29, driven by a record rally in European shares, softened U.S. tariff expectations on China, and prospects of further rate cuts by major central banks. Investors pumped a robust $15.2 billion into global equity funds during the week, which was …
Global equity funds draw biggest weekly inflow in five weeks Read More »
STUTTGART (Reuters) – German automotive supplier Robert Bosch said on Friday that its operating profit plummeted by a third to 3.2 billion euros ($3.32 billion) in 2024, a reflection of a wider crisis in the automotive and mechanical engineering industries. According to preliminary figures, revenue contracted slightly to 90.5 billion euros, while the company’s EBIT …
Bosch sees 2024 operating profit plummet by a third Read More »
By Ludwig Burger FRANKFURT (Reuters) -Novartis on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug Entresto and newer multiple sclerosis drug Kesimpta exceeded forecasts. Fourth-quarter net income, adjusted for special items, rose 26% to $3.93 billion, the Swiss drugmaker said in a statement, surpassing an analyst consensus …
Novartis beats Q4 earnings consensus as drug sales surge Read More »
FRANKFURT (Reuters) – Euro zone manufacturers are more worried about cheap imports from China than tariffs from the United States, a European Central Bank survey showed on Friday. Only half of the manufacturers contacted by the ECB in a regular poll thought their business in the euro area would be affected by U.S. tariffs. Many …
Euro zone manufacturers fear China imports more than US tariffs, ECB survey shows Read More »
PARIS (Reuters) – France’s EDF has raised its nuclear production forecasts for 2025 and beyond, after a strong rebound in output in 2024 and its new Flamanville 3 reactor came online. The state-owned power giant lifted its production forecast late on Thursday to between 350 and 370 terawatt-hours (TWh), up from the 335-365 TWh previously …
French nuclear giant EDF lifts production forecast for 2025 and beyond Read More »
By Emma Farge BELLINZONA, Switzerland (Reuters) – Swiss judges will issue a verdict on Friday in a corruption trial involving commodities trader Trafigura and three other defendants who allegedly paid bribes to an Angolan oil official in exchange for oil deals. The case is the first time in Switzerland that a company has been charged …
Swiss court to rule on landmark Trafigura corruption case Read More »
(Reuters) – Spanish online travel booking company eDreams ODIGEO on Friday said it expects its core earnings to almost double by 2026 as it keeps adding more paying subscribers to its premium service. The company expects its cash earnings before interest, taxes, depreciation and amortization to rise to between 215 million euros ($223.69 million) and …
Spain’s eDreams sees core earnings almost doubling by 2026 Read More »
MOSCOW (Reuters) – Russia’s second-largest oil producer Lukoil plans to raise around $2 billion from the sale of its Burgas oil refinery in Bulgaria, RIA news agency reported late on Thursday quoting Bulgaria’s Prime Minister Rosen Zhelyazkov. Lukoil did not reply to a request for immediate comment. Lukoil has been under pressure to sell the …
Russia’s Lukoil eyes $2 billion from Bulgaria refinery sale, RIA reports Read More »
